Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus
Clinical trial NCT03723551 · TERMINATED
Trial details
- NCT number
- NCT03723551
- Sponsor
- Debiopharm International SA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-20
- Primary completion
- 2025-04-23
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.